trending Market Intelligence /marketintelligence/en/news-insights/trending/Bq0mWtQxtHu4Iq7e7tVMug2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

CASI Pharmaceuticals to offer $23.8M in common stock, warrants

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


CASI Pharmaceuticals to offer $23.8M in common stock, warrants

CASI Pharmaceuticals, Inc. will sell about $23.8 million of securities in a registered direct offering to certain institutional and accredited investors, including existing shareholders.

The company agreed to sell about 7,951,868 common shares and warrants to buy common shares. Each unit, consisting of 1 common share and a warrant to buy 0.2 common share will be priced at $3.00.

The warrants have a term of 2.5 years and an exercise price equal to $3.75. They will be exercisable six months after issuance.

CASI expects to receive net proceeds of about $23.3 million from the offering, which is expected to close Oct. 17, subject to satisfaction of customary closing conditions.

Wei-Wu He, the company's chairman, said CASI plans to use the net proceeds to support business development activities and drive continued growth.

HC Wainwright acted as exclusive placement agent in this transaction.